查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1738436

維生素 D 市場 - 全球產業規模、佔有率、趨勢、機會和預測，按銷售管道（直接、間接）、最終用途（動物飼料、藥品、食品和飲料、個人護理、其他）、按地區和競爭情況分類，2020 年至 2030 年預測

Vitamin D Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Animal Feed, Pharmaceuticals, Food & Beverages, Personal Care, Others), By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年，全球維生素D市場規模達1.1676億美元，預計2030年將達到1.6618億美元，複合年成長率為5.22%。維生素D常被稱為“陽光維生素”，因其預防性健康特性和治療相關性而日益受到認可。由於日照減少、久坐不動的生活方式和飲食攝取不足，維生素D缺乏症病例不斷增加，這導致對維生素D補充劑的需求增加。老年人群尤其需要維生素D補充劑，因為他們更容易患骨質疏鬆症等骨骼相關疾病。人們對預防性醫療保健的日益成長的偏好、針對維生素D更廣泛健康益處的持續臨床研究以及給藥方式的創新，正在進一步加速市場成長。然而，不斷變化的監管框架、供應鏈的不一致以及維生素D天然合成的地區差異等挑戰仍在影響市場動態。儘管存在這些障礙，但在人們認知度不斷提高和產品多樣化的推動下，維生素D的前景仍然樂觀。

市場概覽
預測期 2026-2030
2024年市場規模 1.1676億美元
2030年市場規模 1.6618億美元
2025-2030 年複合年成長率 5.22%
成長最快的領域 直接的
最大的市場 北美洲

關鍵市場促進因素

製藥業的成長

主要市場挑戰

部分地區消費者認知度有限

主要市場趨勢

維生素D缺乏症盛行率不斷上升

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：COVID-19 對全球維生素 D 市場的影響

第5章：全球維生素 D 市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按銷售管道（直接、間接）
    • 依最終用途（動物飼料、藥品、食品和飲料、個人護理、其他）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美維生素D市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第7章：歐洲維生素D市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章：亞太維生素 D 市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第9章：南美維生素D市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東與非洲維生素 D 市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 產品發布（如有）
  • 最新動態

第 13 章：全球維生素 D 市場：SWOT 分析

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章：競爭格局

  • Zhe jiang Garden Biopharmaceutical Co.,Ltd.
  • Zhejiang Xinhecheng Co Ltd
  • Xiamen Jindawei Vitamin Co., Ltd
  • Fermenta Biotech Ltd
  • Taizhou Haisheng Pharmaceutical Co Ltd
  • Zhejiang Medicine Co., Ltd
  • ZHEJIANG WEISHI BIOTECHNOLOGY CO.,LTD.
  • DSM-Firmenich
  • Xi'an Healthful Biotechnology Co., Ltd.
  • CARBOGEN AMCIS

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 29294

The Global Vitamin D Market was valued at USD 116.76 Million in 2024 and is projected to reach USD 166.18 Million by 2030, registering a CAGR of 5.22%. Often referred to as the "sunshine vitamin," Vitamin D has gained increasing recognition for its preventive health attributes and therapeutic relevance. Rising cases of Vitamin D deficiency, driven by reduced sun exposure, sedentary lifestyles, and inadequate dietary intake, are contributing to higher demand for supplementation. This need is particularly acute among older populations, who are more susceptible to bone-related conditions such as osteoporosis. The growing preference for preventive healthcare, ongoing clinical research into Vitamin D's broader health benefits, and innovations in delivery formats are further accelerating market growth. However, challenges such as evolving regulatory frameworks, supply chain inconsistencies, and regional disparities in natural synthesis of the vitamin continue to impact market dynamics. Despite these hurdles, the outlook for Vitamin D remains positive, fueled by increasing awareness and product diversification.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 116.76 Million
Market Size 2030USD 166.18 Million
CAGR 2025-20305.22%
Fastest Growing SegmentDirect
Largest MarketNorth America

Key Market Drivers

Growth in Pharmaceutical Industry

The consistent growth of the global pharmaceutical sector, now valued at approximately USD 1.6 trillion as of 2023, has significantly influenced the Vitamin D market. As an essential nutrient for maintaining bone density, enhancing immune response, and reducing risks of chronic diseases, Vitamin D is being increasingly incorporated into pharmaceutical formulations. Rising global awareness of Vitamin D deficiency-especially among aging populations and individuals with limited sun exposure-has led to the launch of various supplements, tablets, and injectable products. For instance, in 2022, Arbro Pharmaceuticals introduced Vkap-D3, a plant-based supplement containing 60,000 IU of Vitamin D3 in a vegetarian capsule, tailored for effective deficiency treatment. Pharmaceutical advancements have also extended the vitamin's application across preventive therapies for conditions like osteoporosis, autoimmune disorders, and certain respiratory illnesses, thereby boosting market demand.

Key Market Challenges

Limited Consumer Awareness in Some Regions

A major challenge for the Vitamin D market is the lack of consumer awareness in several regions, particularly across parts of Asia, Africa, and Latin America. While developed markets are witnessing increased awareness regarding the consequences of Vitamin D deficiency, underserved regions often lack educational initiatives and healthcare infrastructure to support diagnosis and treatment. Limited awareness about deficiency symptoms-such as fatigue, muscle weakness, and bone discomfort-often results in misdiagnosis or neglect, thereby dampening demand for supplements. The absence of robust government-led health campaigns and nutritional literacy further contributes to the underdiagnosis and low product penetration in these regions.

Key Market Trends

Increasing Prevalence of Vitamin D Deficiency

The growing incidence of Vitamin D deficiency is emerging as a dominant trend in shaping the global market. Countries such as India, Pakistan, Tunisia, and Afghanistan report alarmingly low 25(OH)D levels in over 20% of their populations, with India alone accounting for approximately 490 million affected individuals. Contributing factors include decreased outdoor activity, urban living conditions, excessive sunblock use, and dietary preferences lacking sufficient natural sources of the vitamin. These patterns have resulted in a surge in demand for supplementation and fortified products. Healthcare professionals increasingly recommend Vitamin D intake to address a wide range of conditions-from bone health to immune function-prompting higher adoption of both clinical and consumer-grade formulations.

Key Market Players

  • Zhe jiang Garden Biopharmaceutical Co., Ltd.
  • Zhejiang Xinhecheng Co Ltd
  • Xiamen Jindawei Vitamin Co., Ltd
  • Fermenta Biotech Ltd
  • Taizhou Haisheng Pharmaceutical Co Ltd
  • Zhejiang Medicine Co., Ltd
  • ZHEJIANG WEISHI BIOTECHNOLOGY CO., LTD.
  • DSM-Firmenich
  • Xi'an Healthful Biotechnology Co., Ltd.
  • CARBOGEN AMCIS

Report Scope

In this report, the Global Vitamin D Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vitamin D Market, By Sales Channel:

  • Direct
  • Indirect

Vitamin D Market, By End Use:

  • Animal Feed
  • Pharmaceuticals
  • Food & Beverages
  • Personal Care
  • Others

Vitamin D Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vitamin D Market.

Available Customizations

Global Vitamin D Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Vitamin D Market

5. Global Vitamin D Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Sales Channel (Direct, Indirect)
    • 5.2.2. By End Use (Animal Feed, Pharmaceuticals, Food & Beverages, Personal Care, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Vitamin D Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Sales Channel
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Vitamin D Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Sales Channel
        • 6.3.1.2.2. By End Use
    • 6.3.2. Mexico Vitamin D Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Sales Channel
        • 6.3.2.2.2. By End Use
    • 6.3.3. Canada Vitamin D Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Sales Channel
        • 6.3.3.2.2. By End Use

7. Europe Vitamin D Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Sales Channel
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Vitamin D Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Sales Channel
        • 7.3.1.2.2. By End Use
    • 7.3.2. Germany Vitamin D Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Sales Channel
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Vitamin D Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Sales Channel
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Vitamin D Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Sales Channel
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Vitamin D Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Sales Channel
        • 7.3.5.2.2. By End Use

8. Asia Pacific Vitamin D Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Sales Channel
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Vitamin D Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Sales Channel
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Vitamin D Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Sales Channel
        • 8.3.2.2.2. By End Use
    • 8.3.3. South Korea Vitamin D Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Sales Channel
        • 8.3.3.2.2. By End Use
    • 8.3.4. Japan Vitamin D Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Sales Channel
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Vitamin D Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Sales Channel
        • 8.3.5.2.2. By End Use

9. South America Vitamin D Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Sales Channel
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Vitamin D Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Sales Channel
        • 9.3.1.2.2. By End Use
    • 9.3.2. Argentina Vitamin D Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Sales Channel
        • 9.3.2.2.2. By End Use
    • 9.3.3. Colombia Vitamin D Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Sales Channel
        • 9.3.3.2.2. By End Use

10. Middle East and Africa Vitamin D Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Sales Channel
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Vitamin D Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Sales Channel
        • 10.3.1.2.2. By End Use
    • 10.3.2. Saudi Arabia Vitamin D Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Sales Channel
        • 10.3.2.2.2. By End Use
    • 10.3.3. UAE Vitamin D Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Sales Channel
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Vitamin D Market: SWOT Analysis

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Zhe jiang Garden Biopharmaceutical Co.,Ltd.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Zhejiang Xinhecheng Co Ltd
  • 15.3. Xiamen Jindawei Vitamin Co., Ltd
  • 15.4. Fermenta Biotech Ltd
  • 15.5. Taizhou Haisheng Pharmaceutical Co Ltd
  • 15.6. Zhejiang Medicine Co., Ltd
  • 15.7. ZHEJIANG WEISHI BIOTECHNOLOGY CO.,LTD.
  • 15.8. DSM-Firmenich
  • 15.9. Xi'an Healthful Biotechnology Co., Ltd.
  • 15.10. CARBOGEN AMCIS

16. Strategic Recommendations

17. About Us & Disclaimer